{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T19:28:36Z","timestamp":1716924516274},"reference-count":8,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2018,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>We present the case of a 35-year-old woman with metastatic neuroendocrine tumor undergoing treatment with long-acting octreotide and <jats:sup>177<\/jats:sup>Lu-DOTATATE therapy. We present features of carcinoid heart disease on <jats:sup>68<\/jats:sup>Ga-DOTANOC PET\/CT, which revealed dilated right atrium, pericardial effusion, ascites, and congestive hepatopathy apart from the metastatic lesions in the liver. The scan cardiac findings were confirmed by echocardiography. This highlights the significance of identifying such patients early because additional management is required for carcinoid heart disease per se and a cautious approach is needed in administering amino acid infusion during PRRT that can result in fluid overload.<\/jats:p>","DOI":"10.1097\/rlu.0000000000002139","type":"journal-article","created":{"date-parts":[[2018,6,19]],"date-time":"2018-06-19T17:55:24Z","timestamp":1529430924000},"page":"e280-e281","source":"Crossref","is-referenced-by-count":4,"title":["Somatostatin Receptor PET\/CT Features of Carcinoid Heart Disease"],"prefix":"10.1097","volume":"43","author":[{"given":"Saurabh","family":"Arora","sequence":"first","affiliation":[{"name":"Nuclear Medicine,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Averilicia","family":"Passah","sequence":"additional","affiliation":[{"name":"Nuclear Medicine,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nishikant A.","family":"Damle","sequence":"additional","affiliation":[{"name":"Nuclear Medicine,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajiv","family":"Narang","sequence":"additional","affiliation":[{"name":"Cardiology, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atul","family":"Sharma","sequence":"additional","affiliation":[{"name":"Medical Oncology, All India Institute of Medical Sciences, New Delhi, India."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madhav P.","family":"Yadav","sequence":"additional","affiliation":[{"name":"Nuclear Medicine,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjana","family":"Ballal","sequence":"additional","affiliation":[{"name":"Nuclear Medicine,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dinkar","family":"Bhasin","sequence":"additional","affiliation":[{"name":"Cardiology, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chandrasekhar","family":"Bal","sequence":"additional","affiliation":[{"name":"Nuclear Medicine,"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"bib1-20230925","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1136\/hrt.2004.040329","article-title":"Carcinoid heart disease: presentation, diagnosis, and management","volume":"90","year":"2004","journal-title":"Heart"},{"key":"bib2-20230925","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1053\/j.gastro.2005.03.038","article-title":"Current status of gastrointestinal carcinoids","volume":"128","year":"2005","journal-title":"Gastroenterology"},{"key":"bib3-20230925","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/j.1749-6632.1994.tb17296.x","article-title":"Metastatic carcinoid tumors and the malignant carcinoid syndrome","volume":"733","year":"1994","journal-title":"Ann NY Acad Sci"},{"key":"bib4-20230925","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1161\/01.CIR.29.2.253","article-title":"Carcinoid heart disease with left sided lesions","volume":"29","year":"1964","journal-title":"Circulation"},{"key":"bib5-20230925","first-page":"1","article-title":"Carcinoid heart disease: a clinical pathologic, and therapeutic update","volume":"6","year":"1982","journal-title":"Curr Probl Cardiol"},{"key":"bib6-20230925","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1161\/01.CIR.87.4.1188","article-title":"Carcinoid heart disease. Clinical and echocardiographic spectrum in 74 patients","volume":"87","year":"1993","journal-title":"Circulation"},{"key":"bib7-20230925","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1056\/NEJM199903183401107","article-title":"Carcinoid tumors","volume":"340","year":"1999","journal-title":"N Engl J Med"},{"key":"bib8-20230925","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1046\/j.1365-2036.2001.00924.x","article-title":"Severe impairment of postprandial cholecystokinin release and gall-bladder emptying and high risk of gallstone formation in acromegalic patients during Sandostatin LAR","volume":"15","year":"2001","journal-title":"Aliment Pharmacol Ther"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00003072-201808000-00033","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T05:06:29Z","timestamp":1695618389000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003072-201808000-00033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":8,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000002139","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"value":"1536-0229","type":"electronic"},{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]}}}